Multi-label classification for biomedical literature: an overview of the
  BioCreative VII LitCovid Track for COVID-19 literature topic annotations
  The COVID-19 pandemic has been severely impacting global society since
December 2019. Massive research has been undertaken to understand the
characteristics of the virus and design vaccines and drugs. The related
findings have been reported in biomedical literature at a rate of about 10,000
articles on COVID-19 per month. Such rapid growth significantly challenges
manual curation and interpretation. For instance, LitCovid is a literature
database of COVID-19-related articles in PubMed, which has accumulated more
than 200,000 articles with millions of accesses each month by users worldwide.
One primary curation task is to assign up to eight topics (e.g., Diagnosis and
Treatment) to the articles in LitCovid. Despite the continuing advances in
biomedical text mining methods, few have been dedicated to topic annotations in
COVID-19 literature. To close the gap, we organized the BioCreative LitCovid
track to call for a community effort to tackle automated topic annotation for
COVID-19 literature. The BioCreative LitCovid dataset, consisting of over
30,000 articles with manually reviewed topics, was created for training and
testing. It is one of the largest multilabel classification datasets in
biomedical scientific literature. 19 teams worldwide participated and made 80
submissions in total. Most teams used hybrid systems based on transformers. The
highest performing submissions achieved 0.8875, 0.9181, and 0.9394 for macro
F1-score, micro F1-score, and instance-based F1-score, respectively. The level
of participation and results demonstrate a successful track and help close the
gap between dataset curation and method development. The dataset is publicly
available via https://ftp.ncbi.nlm.nih.gov/pub/lu/LitCovid/biocreative/ for
benchmarking and further development.
